April 22, 2024

bio:cap europe 2026

bio:cap europe 2026

bio:cap europe

bio:cap is Europe’s Life Science & AI Investival with one clear mission:
connecting breakthrough science to the funding that turns ideas into impact.

We unite global investors, founders, and industry leaders to spotlight and back the most promising innovations emerging from European research. bio:cap transforms cutting-edge science into investable ventures and fast-tracks their journey from lab bench to market front.

Our goal?
to benefit patients and society and to help create a resilient and sustainable European bioeconomy.

What is an Investival?

An Investival combines the best of both worlds: investment and festival.

bio:cap blends the depth of a traditional investor conference with the energy, openness, and creativity of a festival. Expect inspiring keynotes, curated matchmaking, and deep-dive sessions by day – followed by relaxed networking and standout social events in the evening. bio:cap is more than just a conference – it’s where deals, ideas, and visions come to life in a whole new atmosphere.

09 – 11 June 2026
CityCube, Messe Berlin


BioRN members receive a 60 % discount for the first 100 Tickets and 10% discount on booth bookings (valid until March 31, 2026)

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
Study shows how lymph node architecture affects cancer growth

Study shows how lymph node architecture affects cancer growth

A new study maps the organisation of immune and stromal cells in lymph nodes and shows how loss of this organisation affects prognosis in certain lymphomas Summary Researchers from EMBL Heidelberg, Heinrich Heine University Düsseldorf (HHU), and Düsseldorf University Hospital (UKD) have succeeded for the first time in mapping the organisation of immune and stromal […]

High-throughput testing of drugs on mini-tumors reveals vulnerabilities in meningiomas

High-throughput testing of drugs on mini-tumors reveals vulnerabilities in meningiomas

Meningiomas are the most common brain tumors. Until now, only two methods have generally been considered for treating them: surgery and radiation therapy. A research team in Heidelberg has now developed a potential new approach for effective systemic therapy. Its members from Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital (UKHD) tested the effectiveness […]

Development of a method for improved monitoring of the early stages of bone marrow cancer

Development of a method for improved monitoring of the early stages of bone marrow cancer

An international team, including researchers from Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital, has developed the PANGEA-SMM prognostic tool. This tool makes it possible to determine with greater accuracy than before whether a precancerous condition—known as “smoldering multiple myeloma”—is progressing and thus requires treatment. The free online tool for treatment teams is available […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp